The risk of new H zoster infection was studied among nearly 30,000 new biologic starts and compared rates seen with abatacept, adalimumab, rituximab, infliximab, etanercept, tocilizumab, certolizumab or golimumab initiation.
A psoriasis population survey finds psoriasis or psoriatic arthritis in 1.4%-3.3% of North American and European households. Many (27-53%) rated their disease as “severe”.
Drug Safety Bulletin: Drug Shortages
Patients in a large Swedish registry with ankylosing spondylitis (AS) and spondyloarthritis (SpA) who started a TNF inhibitor were followed for comedication use and TNF inhibitor survival.
Fibromyalgia is a highly prevalent disorder with different studies and populations showing a prevalence of 2.1% to 6.4% in the general population. A retrospective review from Olmstead county revealed that among 1
A retrospective study of the national register in Sweden identified a total of 11,030 cases with an ankylosing spondylitis (AS) diagnosis (as of 2009) were identified in the National Patient Register, giving a point prevalence of 0.18% in 2009. Men had a higher prevalence of ankylo
Patients rate communication as one of the most important factors in choosing and sticking with a physician. The end product in at least 2/3 of visits is the prescription, yet prescription adherence is substandard in half of our patients. The key is communication.
In the mid-1990s, our Rheumatology Division at the University of Texas Southwestern Medical School became involved with an early trial of a brand new TNF inhibitor.
Current Sunshine Act disclosures do not apply to CME certified educational activities for either the participants or the presenters. CMS has debated and waffled on whether companies would be required to report payments to doctors who speak at, or attend, CME seminars.
Randomized clinical trials are needed to show efficacy and safety, and are needed to back up the claims and indications for a particular drug. The issue of treatment choice has become challenging, especially when choosing to start or augment therapy.
An advisory board has recommended osteoarthritis and a host of disorders for inclusion in the Illinois new medical marijuana program.
In the last 12 months, levothyroxine (Synthroid) was the most prescribed drug in the USA with 21.6 million prescriptions. Adalimumab (Humira) had 8.3 billion in sales, followed by etanercept (Enbrel) at nearly $6 billion.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
